SuperworthVera Therapeutics shares outstanding VERA
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 71.8M
- On a year earlier
- +12.6%
- more shares
Vera Therapeutics had 71.8M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 12.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 65.6M | +8% |
| FY2024 | 60.7M | +37% |
| FY2023 | 44.4M | +60% |
| FY2022 | 27.7M | +30% |
| FY2021 | 21.3M | +6731% |
| FY2020 | 311.5K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 71.8M | +13% | |
| Q1 FY26 | 71.5M | +12% | |
| Q4 FY25 | 65.6M | +8% | |
| Q3 FY25 | 63.8M | +16% | |
| Q2 FY25 | 63.8M | +17% | |
| Q1 FY25 | 63.7M | +25% | |
| Q4 FY24 | 60.7M | +37% | |
| Q3 FY24 | 54.9M | +24% | |
| Q2 FY24 | 54.7M | +24% | |
| Q1 FY24 | 51M | +35% | |
| Q4 FY23 | 44.4M | +60% | |
| Q3 FY23 | 44.4M | +63% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Vera Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.